{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:27:07Z","timestamp":1648798027734},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.diagmicrobio.2008.04.002","type":"journal-article","created":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T01:33:40Z","timestamp":1234920820000},"page":"339-341","source":"Crossref","is-referenced-by-count":1,"title":["In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects"],"prefix":"10.1016","volume":"63","author":[{"given":"Ronald N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib1","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib3","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib4","first-page":"332","article-title":"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib5","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Seventh Edition, M7-A7","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib6","series-title":"Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement (M100-S18)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2005.10.052","article-title":"Dihydrofolate reductase inhibitors as antibacterial agents","volume":"71","author":"Hawser","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in central Japan in 2001\u20132002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2005.06.014","article-title":"Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains","volume":"53","author":"Jones","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/JCM.27.12.2758-2766.1989","article-title":"Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline","volume":"27","author":"Jones","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/AAC.48.5.1885-1886.2004","article-title":"In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae","volume":"48","author":"Kohlhoff","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/jac\/dkm392","article-title":"Effect of human plasma on the antimicrobial activity of iclaprim in vitro","volume":"60","author":"Laue","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/jac\/dkm409","article-title":"In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action","volume":"60","author":"Laue","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1086\/511422","article-title":"Update on the management of gonorrhea in adults in the United States","volume":"44","author":"Newman","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"Proctor","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/j.bmcl.2003.07.023","article-title":"Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria","volume":"13","author":"Schneider","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2004.02.005","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993\u20132002: continuous increasing of ciprofloxacin-resistant isolates","volume":"24","author":"Tanaka","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/22.4.463","article-title":"The effect of media on antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"22","author":"Woodford","year":"1988","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.04.002_bib19","first-page":"488","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002","volume":"27","author":"World Health Organization","year":"2003","journal-title":"Commun Dis Intell"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308001983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308001983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:05:12Z","timestamp":1589580312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308001983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0732889308001983"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.04.002","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}